ArticleFrontiers in immunology2022

SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease.

Erica Novo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.